serum
sampl
patient
sever
acut
respiratori
syndrom
sar
test
nucleocapsid
n
protein
sarsassoci
coronaviru
sensit
first
day
day
onset
respect
specif
n
protein
use
earli
diagnost
maker
sar
e
arli
laboratori
diagnosi
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
one
step
prevent
recurr
global
outbreak
avail
complet
genom
sequenc
sarscov
facilit
develop
varieti
diagnost
test
sar
revers
transcriptionpolymeras
chain
reaction
rtpcr
use
rapid
diagnost
test
research
center
last
epidem
howev
earli
diagnosi
sar
remain
problem
nonresearch
laboratori
littl
experi
molecular
test
develop
antigencaptur
enzymelink
immunosorb
assay
elisa
base
monoclon
antibodi
nucleocapsid
n
protein
sarscov
predomin
antigen
produc
infect
cellcultur
filtrat
high
level
circul
n
protein
detect
serum
sampl
patient
sar
attempt
demonstr
tempor
profil
n
protein
antibodi
serum
sampl
larg
cohort
patient
sar
acut
convalesc
phase
diseas
find
suggest
detect
n
protein
serum
use
earli
diagnost
marker
sar
sar
epidem
guangzhou
serum
specimen
collect
patient
day
onset
symptom
condit
patient
diagnos
accord
world
health
organ
criteria
confirm
seroconvers
fourfold
increas
antibodi
titer
sarscov
mean
immunofluoresc
test
n
proteincaptur
elisa
perform
briefli
serum
ad
well
microtit
plate
coat
mixtur
three
antin
protein
monoclon
antibodi
plate
incub
min
plate
wash
antin
rabbit
antiserum
ad
well
plate
incub
min
well
wash
incub
h
peroxidaseconjug
goat
antirabbit
immunoglobulin
ig
g
plate
wash
tetramethylbenzidin
solut
ad
well
experi
involv
use
serum
sampl
patient
sar
perform
within
safeti
cabinet
biosafeti
level
laboratori
result
serum
specimen
test
n
proteincaptur
elisa
shown
figur
n
protein
could
detect
earli
day
day
serum
sampl
posit
n
protein
optic
densiti
od
valu
highli
variabl
one
sampl
anoth
day
sensit
detect
patient
blood
sampl
taken
first
day
patient
sampl
taken
day
onset
symptom
detect
rate
n
protein
decreas
day
onset
symptom
serum
n
protein
figur
n
protein
detect
serum
sampl
patient
sever
acut
respiratori
syndrom
sar
data
repres
optic
densiti
nm
od
undilut
serum
sampl
establish
normal
rang
n
proteincaptur
enzymelink
immunosorb
assay
serum
specimen
healthi
blood
donor
analyz
mean
od
specimen
determin
assay
standard
deviat
cutoff
od
assay
calcul
follow
cutoff
mean
od
normal
serum
sampl
x
standard
deviat
solid
line
repres
cutoff
valu
result
consid
posit
sampl
yield
od
cutoff
never
detect
beyond
day
use
panel
patient
serum
sampl
measur
n
proteinspecif
igg
sarscov
nigg
sarscovspecif
igg
sarscov
igg
serum
sampl
indirect
elisa
progress
increas
day
onward
figur
appear
antibodi
n
protein
detect
rate
decreas
day
onset
symptom
howev
day
day
high
level
n
protein
still
detect
serum
sampl
patient
mean
od
valu
sarscov
nigg
alreadi
increas
level
mean
od
valu
serum
sampl
patient
collect
year
previous
use
neg
control
patient
thought
case
sar
admiss
later
found
uninfect
serolog
test
healthcar
worker
close
contact
sar
patient
test
circul
n
protein
serum
sampl
nonsar
patient
collect
year
previous
n
one
weakli
posit
n
protein
od
test
total
acutephas
serum
sampl
patient
initi
consid
suspect
sar
later
proven
neg
sarscov
serolog
test
convalescentphas
serum
sampl
taken
day
onset
symptom
serum
sampl
healthcar
worker
neg
n
protein
captur
elisa
find
result
test
specif
result
suggest
n
protein
serum
sampl
sar
patient
detect
earli
day
diseas
onset
although
level
circul
n
protein
highli
variabl
one
person
anoth
day
day
develop
sarscov
nigg
appear
affect
n
protein
acut
phase
infect
day
onset
symptom
posit
detect
rate
n
protein
serum
sampl
within
first
day
infect
higher
detect
furthermor
variat
report
sensit
specif
rtpcr
may
relat
lack
standard
assay
specimen
collect
therefor
viral
antigencaptur
elisa
may
greater
sensit
specif
eas
reliabl
inus
perform
nucleic
acid
amplif
assay
compar
studi
nucleic
acid
amplif
test
undertaken
clinic
laboratori
serv
acutecar
hospit
rapid
sar
diagnosi
vital
thank
rongchang
chen
yuanda
xu
provid
clinic
data
analysi
serum
sampl
patient
sever
acut
respiratori
syndrom
sar
test
nucleocapsid
n
protein
sarsassoci
coronaviru
sensit
first
day
day
onset
respect
specif
n
protein
use
earli
diagnost
maker
sar
e
arli
laboratori
diagnosi
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
one
step
prevent
recurr
global
outbreak
avail
complet
genom
sequenc
sarscov
facilit
develop
varieti
diagnost
test
sar
revers
transcriptionpolymeras
chain
reaction
rtpcr
use
rapid
diagnost
test
research
center
last
epidem
howev
earli
diagnosi
sar
remain
problem
nonresearch
laboratori
littl
experi
molecular
test
develop
antigencaptur
enzymelink
immunosorb
assay
elisa
base
monoclon
antibodi
nucleocapsid
n
protein
sarscov
predomin
antigen
produc
infect
cellcultur
filtrat
high
level
circul
n
protein
detect
serum
sampl
patient
sar
attempt
demonstr
tempor
profil
n
protein
antibodi
serum
sampl
larg
cohort
patient
sar
acut
convalesc
phase
diseas
find
suggest
detect
n
protein
serum
use
earli
diagnost
marker
sar
sar
epidem
guangzhou
serum
specimen
collect
patient
day
onset
symptom
condit
patient
diagnos
accord
world
health
organ
criteria
confirm
seroconvers
fourfold
increas
antibodi
titer
sarscov
mean
immunofluoresc
test
n
proteincaptur
elisa
perform
briefli
serum
ad
well
microtit
plate
coat
mixtur
three
antin
protein
monoclon
antibodi
plate
incub
min
plate
wash
antin
rabbit
antiserum
ad
well
plate
incub
min
well
wash
incub
h
peroxidaseconjug
goat
antirabbit
immunoglobulin
ig
g
plate
wash
tetramethylbenzidin
solut
ad
well
experi
involv
use
serum
sampl
patient
sar
perform
within
safeti
cabinet
biosafeti
level
laboratori
result
serum
specimen
test
n
proteincaptur
elisa
shown
figur
n
protein
could
detect
earli
day
day
serum
sampl
posit
n
protein
optic
densiti
od
valu
highli
variabl
one
sampl
anoth
day
sensit
detect
patient
blood
sampl
taken
first
day
patient
sampl
taken
day
onset
symptom
detect
rate
n
protein
decreas
day
onset
symptom
serum
n
protein
establish
normal
rang
n
proteincaptur
enzymelink
immunosorb
assay
serum
specimen
healthi
blood
donor
analyz
mean
od
specimen
determin
assay
standard
deviat
cutoff
od
assay
calcul
follow
cutoff
mean
od
normal
serum
sampl
x
standard
deviat
solid
line
repres
cutoff
valu
result
consid
posit
sampl
yield
od
cutoff
never
detect
beyond
day
use
panel
patient
serum
sampl
measur
n
proteinspecif
igg
sarscov
nigg
sarscovspecif
igg
sarscov
igg
serum
sampl
indirect
elisa
progress
increas
day
onward
figur
appear
antibodi
n
protein
detect
rate
decreas
day
onset
symptom
howev
day
day
high
level
n
protein
still
detect
serum
sampl
patient
mean
od
valu
sarscov
nigg
alreadi
increas
level
mean
od
valu
serum
sampl
patient
collect
year
previous
use
neg
control
patient
thought
case
sar
admiss
later
found
uninfect
serolog
test
healthcar
worker
close
contact
sar
patient
test
circul
n
protein
serum
sampl
nonsar
patient
collect
year
previous
n
one
weakli
posit
n
protein
od
test
total
acutephas
serum
sampl
patient
initi
consid
suspect
sar
later
proven
neg
sarscov
serolog
test
convalescentphas
serum
sampl
taken
day
onset
symptom
serum
sampl
healthcar
worker
neg
n
protein
captur
elisa
find
result
test
specif
result
suggest
n
protein
serum
sampl
sar
patient
detect
earli
day
diseas
onset
although
level
circul
n
protein
highli
variabl
one
person
anoth
day
day
develop
sarscov
nigg
appear
affect
n
protein
acut
phase
infect
day
onset
symptom
posit
detect
rate
n
protein
serum
sampl
within
first
day
infect
higher
detect
rtpcr
furthermor
variat
report
sensit
specif
rtpcr
may
relat
lack
standard
assay
specimen
collect
therefor
viral
antigencaptur
elisa
may
greater
sensit
specif
eas
reliabl
inus
perform
nucleic
acid
amplif
assay
compar
studi
nucleic
acid
amplif
test
undertaken
clinic
laboratori
serv
acutecar
hospit
rapid
sar
diagnosi
vital
emerg
infecti
diseas
wwwcdcgoveid
vol
novemb
dispatch
figur
profil
n
protein
detect
blood
antibodi
respons
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
onset
symptom
convalesc
phase
igg
immunoglobulin
g
